Pfenex CEO Evert Schimmelpennink's 2019 pay rises 11% to $1.8M
Pfenex reports 2019 executive compensation
By ExecPay News
Published: April 1, 2020
Pfenex reported fiscal year 2019 executive compensation information on April 1, 2020.
In 2019, five Pfenex executives received on average a compensation package of $901K, a 6% decrease compared to previous year.
Evert B. Schimmelpennink, Chief Executive Officer, received $1.8M in total, which increased by 11% compared to 2018. 43% of Schimmelpennink's compensation, or $777K, was in option awards. Schimmelpennink also received $435K in non-equity incentive plan, $567K in salary, as well as $11K in other compensation.
Martin Brenner, Chief Scientific Officer, received a compensation package of $888K. 38% of the compensation package, or $335K, was in option awards.
Patrick K. Lucy, Chief Business Officer, earned $686K in 2019, a 4% increase compared to previous year.
Susan A. Knudson, Chief Financial Officer, received $649K in 2019, which decreases by 16% compared to 2018.
Shawn Scranton, PharmD, Chief Operating Officer, earned $488K in 2019.